Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML

Chen EC, Fathi AT, Brunner AM

OncoTargets and Therapy 2018, 11:3425-3434

Published Date: 12 June 2018